Spanish biopharmaceutical company, Almirall has announced the appointment of Mercedes Diz as Vice President (VP) of Corporate Strategy.
Diz joined Almirall in 2002 and, since 2021, has held the position of Senior Director of Corporate Strategy, leading key strategic processes and projects for Almirall and defining the priorities to achieve the company’s long-term ambition in medical dermatology.
Among her previous roles at Almirall, Diz has been responsible for managing commercial activities in several affiliates (Austria, Belgium, Netherlands, Nordics, Poland, Switzerland, and the UK), as well as leading global commercial support functions, including Global Alliance Management & Partners and Licensing & Corporate Development.
From 2018 to 2020, Diz led the Global marketing and market access team in charge of the company’s Strategic Global Brands. During her tenure, Almirall launched its first biologic into the psoriasis market.
Mercedes Diz holds a Biochemistry and Molecular Biology degree from Madrid Autonomous University. Before Almirall, she performed local sales and marketing roles at Pfizer, Allergan, DuPont Pharma, and J&J.
Speaking on the appointment of Diz, Carlos Gallardo, Chairman & interim CEO of Almirall said, “Mercedes has been a key player for the company, leading strategic projects for Almirall. Among them, Mercedes, together with a multidisciplinary team, developed Almirall’s Long-Term Strategic Plan, setting the priorities on our journey to become the best Medical Dermatology company. I am convinced that she will continue to bring great value to Almirall as a new member of the Management Board.”
Commenting on joining the management board, Mercedes Diz, Almirall’s VP of Corporate Strategy said, “I am delighted to take on this new challenge and to be able to continue to contribute to the growth of the company. My appointment also reflects the commitment Almirall has to foster internal talent development. My appreciation goes out to the company and to the many incredible colleagues and leaders who inspire me every day to pursue our purpose of transforming patients’ world.”
